ARTICLE

FindCenter AddIcon

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

By Victoria Turk — 2016

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

Read on www.vice.com

FindCenter Post-Image

Largest Ever DMT Survey Travels to the Fringes of Psychedelic Science

Encounters with inter-dimensional beings, atheists discovering belief, and the bizarre world of DMT-induced entities. A trip to the fringes of psychedelic science.

FindCenter AddIcon
FindCenter Post-Image

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Using pharmacokinetic modeling and DMT blood sampling data, we demonstrate that the unique pharmacological characteristics of DMT, which also include a rapid onset and lack of acute tolerance to its subjective effects, make it amenable to administration by target-controlled intravenous infusion.

FindCenter AddIcon

EXPLORE TOPIC

Psilocybin